Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731)

Kapil Suchal; Salma Malik; Nanda Gamad; Rajiv Kumar Malhotra; Sameer N. Goyal; Uma Chaudhary; Jagriti Bhatia; Shreesh Ojha; Dharamvir Singh Arya

doi:10.1155/2020/4530278

Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731)

Kapil Suchal
, Salma Malik
, Nanda Gamad
, Rajiv Kumar Malhotra
, Sameer N. Goyal
, Uma Chaudhary
, Jagriti Bhatia
, Shreesh Ojha
, Dharamvir Singh Arya

Department of Pharmacology and Therapeutics

Research output: Contribution to journal › Comment/debate › peer-review

2 Citations (Scopus)

Abstract

In the article titled "Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury"[1], it was identified that the beta-actin panels in Figures 4(a), 4(b), and 4(c) were identical. With the agreement of the editor, a revised version of Figure 4 is being provided with the data from a repeat of the experiment. The authors apologize for this error in the original publication.

Original language	English
Article number	4530278
Journal	Oxidative medicine and cellular longevity
Volume	2020
DOIs	https://doi.org/10.1155/2020/4530278
Publication status	Published - 2020

ASJC Scopus subject areas

Biochemistry
Ageing
Cell Biology

Access to Document

10.1155/2020/4530278

Fingerprint

Dive into the research topics of 'Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731)'. Together they form a unique fingerprint.

Cite this

Suchal, K., Malik, S., Gamad, N., Malhotra, R. K., Goyal, S. N., Chaudhary, U., Bhatia, J., Ojha, S., & Arya, D. S. (2020). Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731). Oxidative medicine and cellular longevity, 2020, Article 4530278. https://doi.org/10.1155/2020/4530278

Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731). / Suchal, Kapil; Malik, Salma; Gamad, Nanda et al.
In: Oxidative medicine and cellular longevity, Vol. 2020, 4530278, 2020.

Research output: Contribution to journal › Comment/debate › peer-review

Suchal, K, Malik, S, Gamad, N, Malhotra, RK, Goyal, SN, Chaudhary, U, Bhatia, J, Ojha, S & Arya, DS 2020, 'Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731)', Oxidative medicine and cellular longevity, vol. 2020, 4530278. https://doi.org/10.1155/2020/4530278

Suchal K, Malik S, Gamad N, Malhotra RK, Goyal SN, Chaudhary U et al. Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731). Oxidative medicine and cellular longevity. 2020;2020:4530278. doi: 10.1155/2020/4530278

Suchal, Kapil ; Malik, Salma ; Gamad, Nanda et al. / Erratum : Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731). In: Oxidative medicine and cellular longevity. 2020 ; Vol. 2020.

@article{a12ae210499f453796c4a27f24429ba7,

title = "Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731)",

abstract = "In the article titled {"}Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury{"}[1], it was identified that the beta-actin panels in Figures 4(a), 4(b), and 4(c) were identical. With the agreement of the editor, a revised version of Figure 4 is being provided with the data from a repeat of the experiment. The authors apologize for this error in the original publication.",

author = "Kapil Suchal and Salma Malik and Nanda Gamad and Malhotra, \{Rajiv Kumar\} and Goyal, \{Sameer N.\} and Uma Chaudhary and Jagriti Bhatia and Shreesh Ojha and Arya, \{Dharamvir Singh\}",

note = "Publisher Copyright: Copyright {\textcopyright} 2020 Kapil Suchal et al.",

year = "2020",

doi = "10.1155/2020/4530278",

language = "English",

volume = "2020",

journal = "Oxidative medicine and cellular longevity",

issn = "1942-0900",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Erratum

T2 - Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731)

AU - Suchal, Kapil

AU - Malik, Salma

AU - Gamad, Nanda

AU - Malhotra, Rajiv Kumar

AU - Goyal, Sameer N.

AU - Chaudhary, Uma

AU - Bhatia, Jagriti

AU - Ojha, Shreesh

AU - Arya, Dharamvir Singh

PY - 2020

Y1 - 2020

N2 - In the article titled "Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury"[1], it was identified that the beta-actin panels in Figures 4(a), 4(b), and 4(c) were identical. With the agreement of the editor, a revised version of Figure 4 is being provided with the data from a repeat of the experiment. The authors apologize for this error in the original publication.

AB - In the article titled "Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury"[1], it was identified that the beta-actin panels in Figures 4(a), 4(b), and 4(c) were identical. With the agreement of the editor, a revised version of Figure 4 is being provided with the data from a repeat of the experiment. The authors apologize for this error in the original publication.

UR - https://www.scopus.com/pages/publications/85087888669

UR - https://www.scopus.com/pages/publications/85087888669#tab=citedBy

U2 - 10.1155/2020/4530278

DO - 10.1155/2020/4530278

M3 - Comment/debate

C2 - 32655768

AN - SCOPUS:85087888669

SN - 1942-0900

VL - 2020

JO - Oxidative medicine and cellular longevity

JF - Oxidative medicine and cellular longevity

M1 - 4530278

ER -

Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this